Related Experiment Video
Updated: May 11, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic
Supriya D Deshpande1, Sumanth Putta, Mei Wang
1Irell & Manella Graduate School of Biological Sciences, Beckman Research Institute of the City of Hope, Duarte, California, USA.
Abstract:
Elevated p53 expression is associated with several kidney diseases including diabetic nephropathy (DN). However, the mechanisms are unclear. We report that expression levels of transforming growth factor-β1 (TGF-β), p53, and microRNA-192 (miR-192) are increased in the renal cortex of diabetic mice, and this is associated with enhanced glomerular expansion and fibrosis relative to nondiabetic mice. Targeting miR-192 with locked nucleic acid-modified inhibitors in vivo decreases expression of p53 in the renal cortex of control and streptozotocin-injected diabetic mice. Furthermore, mice with genetic deletion of miR-192 in vivo display attenuated renal cortical TGF-β and p53 expression when made diabetic, and have reduced renal fibrosis, hypertrophy, proteinuria, and albuminuria relative to diabetic wild-type mice. In vitro promoter regulation studies show that TGF-β induces reciprocal activation of miR-192 and p53, via the miR-192 target Zeb2, leading to augmentation of downstream events related to DN. Inverse correlation between miR-192 and Zeb2 was observed in glomeruli of human subjects with early DN, consistent with the mechanism seen in mice. Our results demonstrate for the first time a TGF-β-induced feedback amplification circuit between p53 and miR-192 related to the pathogenesis of DN, and that miR-192-knockout mice are protected from key features of DN.
Insights
Transforming growth factor-β1 (TGF-β) induces a feedback loop between p53 and microRNA-192 (miR-192), driving diabetic nephropathy (DN) progression. Inhibiting miR-192 or its genetic deletion protects against DN.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Diabetic nephropathy (DN) is a complication of diabetes, characterized by kidney damage.
- Elevated p53 expression is linked to kidney diseases, but its role in DN pathogenesis is not fully understood.
- Transforming growth factor-β1 (TGF-β) and microRNA-192 (miR-192) are implicated in kidney fibrosis.
Purpose of the Study:
- To elucidate the mechanisms linking p53, TGF-β, and miR-192 in diabetic nephropathy.
- To investigate the therapeutic potential of targeting the miR-192/p53 axis in DN.
Main Methods:
- Analysis of p53, TGF-β, and miR-192 expression in renal cortex of diabetic and control mice.
- In vivo inhibition of miR-192 using locked nucleic acid-modified inhibitors.
- Generation and study of miR-192 knockout mice subjected to diabetes induction.
- In vitro promoter assays to determine regulatory relationships.
- Correlation analysis of miR-192 and Zeb2 in human DN glomeruli.
Main Results:
- Diabetic mice exhibited increased renal TGF-β, p53, and miR-192 expression, correlating with glomerular fibrosis.
- miR-192 inhibition reduced p53 expression in diabetic mice.
- miR-192 knockout mice showed attenuated TGF-β and p53 levels, with reduced DN features (fibrosis, hypertrophy, proteinuria).
- TGF-β induced a feedback loop between miR-192 and p53 via Zeb2, promoting DN.
- Inverse correlation between miR-192 and Zeb2 observed in human DN samples.
Conclusions:
- A novel TGF-β-induced feedback loop between p53 and miR-192 contributes to DN pathogenesis.
- Targeting miR-192 offers a potential therapeutic strategy for diabetic nephropathy.
- miR-192 deficiency protects against key pathological features of diabetic nephropathy.
Related Concept Videos
Diabetic Nephropathy
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
TGF - β Signaling Pathway
Diabetic Retinopathy
PI3K/mTOR/AKT Signaling Pathway
